10 August 2021
Duke Royalty Limited
("Duke Royalty" or "Duke")
Notice of Results and Analyst Presentation
Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, will announce its audited results for the year ending 30 June 2021 ("FY21") on Thursday 16 September 2021.
Details of webinar for equity analysts
There will be a webinar for equity analysts at 09:30am BST on Thursday 16 September 2021, hosted by Neil Johnson, CEO, and Hugo Evans, FD. Any equity analysts wishing to register should contact SEC Newgate at dukeroyalty@secnewgate.co.uk where further details will be provided.
***ENDS***
For further information, please visit www.dukeroyalty.com or contact:
| Duke Royalty Limited | Neil Johnson / Charlie Cannon Brookes / Hugo Evans
| +44 (0) 1481 730 613 |
| Cenkos Securities plc (Nominated Adviser and Joint Broker) | Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson | +44 (0) 207 397 8900 |
| | | |
| Canaccord Genuity (Joint Broker)
| Adam James / Georgina McCooke | +44 (0) 207 523 8000 |
| SEC Newgate (PR) | Elisabeth Cowell/ Richard Bicknell/ Megan Kovach | + +44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk |
About Duke Royalty
Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
